Kodiak Sciences Inc. — Investor Relations & Filings
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on researching, developing, and commercializing therapeutics for chronic, high-prevalence retinal diseases. The company's mission is to address the leading causes of blindness, such as wet age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. Its core technology is the proprietary Antibody Biopolymer Conjugate Drug (ABCD) Platform, which is designed to create long-acting biologics with enhanced durability, potentially reducing treatment frequency for patients. Kodiak's late-stage clinical pipeline includes its lead candidate, tarcocimab tedromer, an anti-VEGF therapy, as well as other candidates targeting retinal vascular diseases and macular edema.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-05-07 | English | |
| 10-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-03-31 | English | |
| 4 - Kodiak Sciences Inc. (0001468748) (Issuer) | 2026-03-27 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 5 Filing | 2026-02-17 | English | |
| Major Shareholding Notification 2025 | 2025-12-19 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 43476817 | 8-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-05-07 | English | ||
| 33122720 | 10-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-03-31 | English | ||
| 33066636 | 4 - Kodiak Sciences Inc. (0001468748) (Issuer) | 2026-03-27 | English | ||
| 29966374 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29966373 | 5 Filing | 2026-02-17 | English | ||
|
2025
10 filings
| |||||
| 12296065 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 12296064 | 4 | 2025-12-19 | English | ||
| 12296068 | 8-K | 2025-12-18 | English | ||
| 12296067 | 424B5 | 2025-12-17 | English | ||
| 12296069 | 424B5 | 2025-12-15 | English | ||
| 12296066 | 10-Q | 2025-11-13 | English | ||
| 12296070 | 8-K | 2025-11-13 | English | ||
| 12296071 | Major Shareholding Notification 2025 | 2025-08-19 | English | ||
| 12296072 | 10-Q | 2025-08-13 | English | ||
| 12296073 | 8-K | 2025-08-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ENANTA PHARMACEUTICALS INC
Biotechnology company developing small molecule drugs for v…
|
ENTA | US | Manufacturing |
|
Enervit
Develops sports nutrition, functional foods, and wellness s…
|
ENV | IT | Manufacturing |
|
enGene Holdings Inc.
Clinical-stage biotech developing non-viral gene therapies …
|
ENGN | CA | Manufacturing |
|
Enliven Therapeutics, Inc.
Clinical-stage biopharma developing kinase inhibitors for p…
|
ELVN | US | Manufacturing |
|
Enlivex Therapeutics Ltd.
Develops macrophage reprogramming immunotherapy for inflamm…
|
ENLV | US | Manufacturing |
|
Enlivex Therapeutics Ltd.
A clinical-stage macrophage reprogramming immunotherapy com…
|
ENLV | IL | Manufacturing |
|
Enorama Pharma AB
Develops and manufactures medicated chewing gums and tobacc…
|
ERMA | SE | Manufacturing |
|
Ensol Biosciences Inc.
AI-driven biopharma developing peptide drugs for unmet medi…
|
140610 | KR | Manufacturing |
|
Entera Bio Ltd.
A clinical-stage company developing oral peptide and protei…
|
ENTX | IL | Manufacturing |
|
Entero Therapeutics, Inc.
Clinical-stage biopharma developing oral therapies for gast…
|
ENTO | US | Manufacturing |
Kodiak Sciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32371/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32371 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32371 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32371 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32371}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kodiak Sciences Inc. (id: 32371)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.